1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Lynn McMahon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia hydroxychloroquine, imatinib mesylate, cytogenetic analysis - Leukemia | Phase 2 | Unknown | Lynn McMahon | 66 | 2010-03-01 | 2011-11-30 |
Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Chronic-Phase (1)
Cytogenetic Analysis (1) · Hydroxychloroquine (1) · Imatinib Mesylate (1) · Polymerase Chain Reaction (1)
United Kingdom (1)